Dealing with uncertainty in drug safety: lessons for the future from sertindole.
Waller
Patrick
P
patrick.waller@btinternet.com
D016907:Adverse Drug Reaction Reporting Systems; D014150:Antipsychotic Agents / Q000009:adverse effects*; D015982:Bias; D016265:Conflict of Interest; D003657:Decision Making; D004562:Electrocardiography / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007211:Indoles / Q000009:adverse effects*; D010506:Periodicals as Topic / Q000592:standards*; D012449:Safety; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration
D014150:Antipsychotic Agents; D007093:Imidazoles; D007211:Indoles; C066304:sertindole